Windsor Group LTD Abb Vie Inc. Transaction History

Windsor Group LTD

$546 Million
Q3 2023

A detailed history of Windsor Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Windsor Group LTD holds 15,534 shares of ABBV stock, worth $3.03 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

15,534

Previous 15,574 0.26%

Holding current value

$3.03 Million

Previous $2.1 Million 10.34%

% of portfolio

0.42%

Previous 0.38%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $5,343 - $6,186	-40 Reduced 0.26%	15,534 $2.32 Million
Q2 2023 Jul 12, 2023	BUY	$132.51 - $164.9 $795 - $989	6 Added 0.04%	15,574 $2.1 Million
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $18,220 - $20,984	-126 Reduced 0.8%	15,568 $2.51 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $414 - $497	-3 Reduced 0.02%	15,694 $2.61 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $5,099 - $5,849	-38 Reduced 0.24%	15,697 $2.18 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $88,352 - $112,324	-642 Reduced 3.92%	15,735 $2.4 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $8,578 - $10,643	65 Added 0.4%	16,377 $2.87 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $195,307 - $247,120	-1,818 Reduced 10.03%	16,312 $2.21 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $44,688 - $50,727	420 Added 2.37%	18,130 $1.98 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $25,566 - $28,482	243 Added 1.39%	17,710 $2 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $97,696 - $107,552	955 Added 5.78%	17,467 $1.89 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $13,683 - $18,473	170 Added 1.04%	16,512 $1.77 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $18,127 - $21,275	-211 Reduced 1.27%	16,342 $1.37 Million
Q2 2020 Jul 06, 2020	BUY	$73.37 - $98.18 $18,562 - $24,839	253 Added 1.55%	16,553 $1.63 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $2,386 - $3,618	-37 Reduced 0.23%	16,300 $1.24 Million
Q4 2019 Jan 07, 2020	BUY	$72.13 - $90.25 $865 - $1,083	12 Added 0.07%	16,337 $1.45 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $13,855 - $16,658	-220 Reduced 1.33%	16,325 $1.24 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $875,781 - $1.12 Million	13,330 Added 414.62%	16,545 $1.21 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $338,953 - $398,931	-4,394 Reduced 57.75%	3,215 $259,000
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $13,468 - $16,609	-173 Reduced 2.22%	7,609 $701,000
Q3 2018 Oct 05, 2018	SELL	$88.91 - $98.84 $93,533 - $103,979	-1,052 Reduced 11.91%	7,782 $736,000
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $26,934 - $31,869	-300 Reduced 3.28%	8,834 $818,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $18,402 - $24,642	200 Added 2.24%	9,134 $865,000
Q4 2017 Mar 01, 2018	BUY	$89.56 - $98.21 $800,129 - $877,408	8,934	8,934 $864,000

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Group LTD with notifications on news.

Account

Windsor Group LTD Abb Vie Inc. Transaction History